" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus
Recruiting
Observational Study
Systemic Lupus Erythematosus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Observational
- Participants needed
- 90 (estimated)
- Sponsor
- South Valley University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by diverse clinical manifestations, prominently involving the skin.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult aged 18-60 years
* Diagnosed as SLE per 2019 EULAR/ACR classification criteria.
* Presence of at least one cutaneous manifestation (acute, subacute, or chronic).
* Willing to provide written informed consent for participation and genetic testing
Exclusion Criteria:
* O…
Contacts